Industry Research Reports

Home > Reports > Pharma & Healthcare > TB Disease Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

TB Disease Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published Date: 2024-01-07

Pages: 130 Pages

Report ld: 3005698

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The vaccine for tuberculosis (TB) is known as BCG (bacille Calmette-Guérin) vaccine. BCG vaccine contains a weakened form of the bacteria (germ) that cause TB. Because it is weakened it doesn't cause TB in healthy people but it helps develop some protection (immunity) against TB.

The global market for TB Disease Vaccine was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

MARKET SEGMENTATION

By Company

Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC
Queen Saovabha Mem. Inst
Microgen

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Prevention Vaccines
Post-exposure Vaccines
Others

Segment by Application

Self-Procurement
UNICEF
Others

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for TB Disease Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of TB Disease Vaccine by region & country, by Type, and by Application.

The TB Disease Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding TB Disease Vaccine.

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of TB Disease Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of TB Disease Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of TB Disease Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 TB Disease Vaccine Product Introduction

1.2 Global TB Disease Vaccine Market Size Forecast

1.2.1 Global TB Disease Vaccine Sales Value (2019-2030)

1.2.2 Global TB Disease Vaccine Sales Volume (2019-2030)

1.2.3 Global TB Disease Vaccine Sales Price (2019-2030)

1.3 TB Disease Vaccine Market Trends & Drivers

1.3.1 TB Disease Vaccine Industry Trends

1.3.2 TB Disease Vaccine Market Drivers & Opportunity

1.3.3 TB Disease Vaccine Market Challenges

1.3.4 TB Disease Vaccine Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global TB Disease Vaccine Players Revenue Ranking (2023)

2.2 Global TB Disease Vaccine Revenue by Company (2019-2024)

2.3 Global TB Disease Vaccine Players Sales Volume Ranking (2023)

2.4 Global TB Disease Vaccine Sales Volume by Company Players (2019-2024)

2.5 Global TB Disease Vaccine Average Price by Company (2019-2024)

2.6 Key Manufacturers TB Disease Vaccine Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers TB Disease Vaccine Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of TB Disease Vaccine

2.9 TB Disease Vaccine Market Competitive Analysis

2.9.1 TB Disease Vaccine Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by TB Disease Vaccine Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in TB Disease Vaccine as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Prevention Vaccines

3.1.2 Post-exposure Vaccines

3.1.3 Others

3.2 Global TB Disease Vaccine Sales Value by Type

3.2.1 Global TB Disease Vaccine Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global TB Disease Vaccine Sales Value, by Type (2019-2030)

3.2.3 Global TB Disease Vaccine Sales Value, by Type (%) (2019-2030)

3.3 Global TB Disease Vaccine Sales Volume by Type

3.3.1 Global TB Disease Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global TB Disease Vaccine Sales Volume, by Type (2019-2030)

3.3.3 Global TB Disease Vaccine Sales Volume, by Type (%) (2019-2030)

3.4 Global TB Disease Vaccine Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Self-Procurement

4.1.2 UNICEF

4.1.3 Others

4.2 Global TB Disease Vaccine Sales Value by Application

4.2.1 Global TB Disease Vaccine Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global TB Disease Vaccine Sales Value, by Application (2019-2030)

4.2.3 Global TB Disease Vaccine Sales Value, by Application (%) (2019-2030)

4.3 Global TB Disease Vaccine Sales Volume by Application

4.3.1 Global TB Disease Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global TB Disease Vaccine Sales Volume, by Application (2019-2030)

4.3.3 Global TB Disease Vaccine Sales Volume, by Application (%) (2019-2030)

4.4 Global TB Disease Vaccine Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global TB Disease Vaccine Sales Value by Region

5.1.1 Global TB Disease Vaccine Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global TB Disease Vaccine Sales Value by Region (2019-2024)

5.1.3 Global TB Disease Vaccine Sales Value by Region (2025-2030)

5.1.4 Global TB Disease Vaccine Sales Value by Region (%), (2019-2030)

5.2 Global TB Disease Vaccine Sales Volume by Region

5.2.1 Global TB Disease Vaccine Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global TB Disease Vaccine Sales Volume by Region (2019-2024)

5.2.3 Global TB Disease Vaccine Sales Volume by Region (2025-2030)

5.2.4 Global TB Disease Vaccine Sales Volume by Region (%), (2019-2030)

5.3 Global TB Disease Vaccine Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America TB Disease Vaccine Sales Value, 2019-2030

5.4.2 North America TB Disease Vaccine Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe TB Disease Vaccine Sales Value, 2019-2030

5.5.2 Europe TB Disease Vaccine Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific TB Disease Vaccine Sales Value, 2019-2030

5.6.2 Asia Pacific TB Disease Vaccine Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America TB Disease Vaccine Sales Value, 2019-2030

5.7.2 South America TB Disease Vaccine Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa TB Disease Vaccine Sales Value, 2019-2030

5.8.2 Middle East & Africa TB Disease Vaccine Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions TB Disease Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions TB Disease Vaccine Sales Value

6.2.1 Key Countries/Regions TB Disease Vaccine Sales Value, 2019-2030

6.2.2 Key Countries/Regions TB Disease Vaccine Sales Volume, 2019-2030

6.3 United States

6.3.1 United States TB Disease Vaccine Sales Value, 2019-2030

6.3.2 United States TB Disease Vaccine Sales Value by Type (%), 2023 VS 2030

6.3.3 United States TB Disease Vaccine Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe TB Disease Vaccine Sales Value, 2019-2030

6.4.2 Europe TB Disease Vaccine Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe TB Disease Vaccine Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China TB Disease Vaccine Sales Value, 2019-2030

6.5.2 China TB Disease Vaccine Sales Value by Type (%), 2023 VS 2030

6.5.3 China TB Disease Vaccine Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan TB Disease Vaccine Sales Value, 2019-2030

6.6.2 Japan TB Disease Vaccine Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan TB Disease Vaccine Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea TB Disease Vaccine Sales Value, 2019-2030

6.7.2 South Korea TB Disease Vaccine Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea TB Disease Vaccine Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia TB Disease Vaccine Sales Value, 2019-2030

6.8.2 Southeast Asia TB Disease Vaccine Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia TB Disease Vaccine Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India TB Disease Vaccine Sales Value, 2019-2030

6.9.2 India TB Disease Vaccine Sales Value by Type (%), 2023 VS 2030

6.9.3 India TB Disease Vaccine Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Merck

7.1.1 Merck Company Information

7.1.2 Merck Introduction and Business Overview

7.1.3 Merck TB Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Merck TB Disease Vaccine Product Offerings

7.1.5 Merck Recent Development

7.2 Japan BCG Lab

7.2.1 Japan BCG Lab Company Information

7.2.2 Japan BCG Lab Introduction and Business Overview

7.2.3 Japan BCG Lab TB Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Japan BCG Lab TB Disease Vaccine Product Offerings

7.2.5 Japan BCG Lab Recent Development

7.3 Serum Institute of India

7.3.1 Serum Institute of India Company Information

7.3.2 Serum Institute of India Introduction and Business Overview

7.3.3 Serum Institute of India TB Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Serum Institute of India TB Disease Vaccine Product Offerings

7.3.5 Serum Institute of India Recent Development

7.4 AJ Vaccines

7.4.1 AJ Vaccines Company Information

7.4.2 AJ Vaccines Introduction and Business Overview

7.4.3 AJ Vaccines TB Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.4.4 AJ Vaccines TB Disease Vaccine Product Offerings

7.4.5 AJ Vaccines Recent Development

7.5 BioFarma

7.5.1 BioFarma Company Information

7.5.2 BioFarma Introduction and Business Overview

7.5.3 BioFarma TB Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.5.4 BioFarma TB Disease Vaccine Product Offerings

7.5.5 BioFarma Recent Development

7.6 GreenSignal Bio Pharma

7.6.1 GreenSignal Bio Pharma Company Information

7.6.2 GreenSignal Bio Pharma Introduction and Business Overview

7.6.3 GreenSignal Bio Pharma TB Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.6.4 GreenSignal Bio Pharma TB Disease Vaccine Product Offerings

7.6.5 GreenSignal Bio Pharma Recent Development

7.7 China National Biotec

7.7.1 China National Biotec Company Information

7.7.2 China National Biotec Introduction and Business Overview

7.7.3 China National Biotec TB Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.7.4 China National Biotec TB Disease Vaccine Product Offerings

7.7.5 China National Biotec Recent Development

7.8 Biomed Lublin

7.8.1 Biomed Lublin Company Information

7.8.2 Biomed Lublin Introduction and Business Overview

7.8.3 Biomed Lublin TB Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Biomed Lublin TB Disease Vaccine Product Offerings

7.8.5 Biomed Lublin Recent Development

7.9 Taj Pharmaceuticals

7.9.1 Taj Pharmaceuticals Company Information

7.9.2 Taj Pharmaceuticals Introduction and Business Overview

7.9.3 Taj Pharmaceuticals TB Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Taj Pharmaceuticals TB Disease Vaccine Product Offerings

7.9.5 Taj Pharmaceuticals Recent Development

7.10 Ataulpho de Paiva

7.10.1 Ataulpho de Paiva Company Information

7.10.2 Ataulpho de Paiva Introduction and Business Overview

7.10.3 Ataulpho de Paiva TB Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Ataulpho de Paiva TB Disease Vaccine Product Offerings

7.10.5 Ataulpho de Paiva Recent Development

7.11 IVAC

7.11.1 IVAC Company Information

7.11.2 IVAC Introduction and Business Overview

7.11.3 IVAC TB Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.11.4 IVAC TB Disease Vaccine Product Offerings

7.11.5 IVAC Recent Development

7.12 Queen Saovabha Mem. Inst

7.12.1 Queen Saovabha Mem. Inst Company Information

7.12.2 Queen Saovabha Mem. Inst Introduction and Business Overview

7.12.3 Queen Saovabha Mem. Inst TB Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.12.4 Queen Saovabha Mem. Inst TB Disease Vaccine Product Offerings

7.12.5 Queen Saovabha Mem. Inst Recent Development

7.13 Microgen

7.13.1 Microgen Company Information

7.13.2 Microgen Introduction and Business Overview

7.13.3 Microgen TB Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.13.4 Microgen TB Disease Vaccine Product Offerings

7.13.5 Microgen Recent Development

8 Industry Chain Analysis

8.1 TB Disease Vaccine Industrial Chain

8.2 TB Disease Vaccine Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 TB Disease Vaccine Sales Model

8.5.2 Sales Channel

8.5.3 TB Disease Vaccine Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. TB Disease Vaccine Market Trends

Table 2. TB Disease Vaccine Market Drivers & Opportunity

Table 3. TB Disease Vaccine Market Challenges

Table 4. TB Disease Vaccine Market Restraints

Table 5. Global TB Disease Vaccine Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global TB Disease Vaccine Revenue Market Share by Company (2019-2024)

Table 7. Global TB Disease Vaccine Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global TB Disease Vaccine Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market TB Disease Vaccine Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers TB Disease Vaccine Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers TB Disease Vaccine Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of TB Disease Vaccine

Table 13. Global TB Disease Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in TB Disease Vaccine as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global TB Disease Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global TB Disease Vaccine Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global TB Disease Vaccine Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global TB Disease Vaccine Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global TB Disease Vaccine Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global TB Disease Vaccine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global TB Disease Vaccine Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global TB Disease Vaccine Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global TB Disease Vaccine Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global TB Disease Vaccine Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global TB Disease Vaccine Price by Type (2019-2024) & (US$/Unit)

Table 27. Global TB Disease Vaccine Price by Type (2025-2030) & (US$/Unit)

Table 28. Global TB Disease Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global TB Disease Vaccine Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global TB Disease Vaccine Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global TB Disease Vaccine Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global TB Disease Vaccine Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global TB Disease Vaccine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global TB Disease Vaccine Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global TB Disease Vaccine Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global TB Disease Vaccine Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global TB Disease Vaccine Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global TB Disease Vaccine Price by Application (2019-2024) & (US$/Unit)

Table 39. Global TB Disease Vaccine Price by Application (2025-2030) & (US$/Unit)

Table 40. Global TB Disease Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global TB Disease Vaccine Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global TB Disease Vaccine Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global TB Disease Vaccine Sales Value by Region (2019-2024) & (%)

Table 44. Global TB Disease Vaccine Sales Value by Region (2025-2030) & (%)

Table 45. Global TB Disease Vaccine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global TB Disease Vaccine Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global TB Disease Vaccine Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global TB Disease Vaccine Sales Volume by Region (2019-2024) & (%)

Table 49. Global TB Disease Vaccine Sales Volume by Region (2025-2030) & (%)

Table 50. Global TB Disease Vaccine Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global TB Disease Vaccine Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions TB Disease Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions TB Disease Vaccine Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions TB Disease Vaccine Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions TB Disease Vaccine Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions TB Disease Vaccine Sales Volume, (2025-2030) & (K Units)

Table 57. Merck Company Information

Table 58. Merck Introduction and Business Overview

Table 59. Merck TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Merck TB Disease Vaccine Product Offerings

Table 61. Merck Recent Development

Table 62. Japan BCG Lab Company Information

Table 63. Japan BCG Lab Introduction and Business Overview

Table 64. Japan BCG Lab TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Japan BCG Lab TB Disease Vaccine Product Offerings

Table 66. Japan BCG Lab Recent Development

Table 67. Serum Institute of India Company Information

Table 68. Serum Institute of India Introduction and Business Overview

Table 69. Serum Institute of India TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. Serum Institute of India TB Disease Vaccine Product Offerings

Table 71. Serum Institute of India Recent Development

Table 72. AJ Vaccines Company Information

Table 73. AJ Vaccines Introduction and Business Overview

Table 74. AJ Vaccines TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. AJ Vaccines TB Disease Vaccine Product Offerings

Table 76. AJ Vaccines Recent Development

Table 77. BioFarma Company Information

Table 78. BioFarma Introduction and Business Overview

Table 79. BioFarma TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. BioFarma TB Disease Vaccine Product Offerings

Table 81. BioFarma Recent Development

Table 82. GreenSignal Bio Pharma Company Information

Table 83. GreenSignal Bio Pharma Introduction and Business Overview

Table 84. GreenSignal Bio Pharma TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. GreenSignal Bio Pharma TB Disease Vaccine Product Offerings

Table 86. GreenSignal Bio Pharma Recent Development

Table 87. China National Biotec Company Information

Table 88. China National Biotec Introduction and Business Overview

Table 89. China National Biotec TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. China National Biotec TB Disease Vaccine Product Offerings

Table 91. China National Biotec Recent Development

Table 92. Biomed Lublin Company Information

Table 93. Biomed Lublin Introduction and Business Overview

Table 94. Biomed Lublin TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. Biomed Lublin TB Disease Vaccine Product Offerings

Table 96. Biomed Lublin Recent Development

Table 97. Taj Pharmaceuticals Company Information

Table 98. Taj Pharmaceuticals Introduction and Business Overview

Table 99. Taj Pharmaceuticals TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 100. Taj Pharmaceuticals TB Disease Vaccine Product Offerings

Table 101. Taj Pharmaceuticals Recent Development

Table 102. Ataulpho de Paiva Company Information

Table 103. Ataulpho de Paiva Introduction and Business Overview

Table 104. Ataulpho de Paiva TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 105. Ataulpho de Paiva TB Disease Vaccine Product Offerings

Table 106. Ataulpho de Paiva Recent Development

Table 107. IVAC Company Information

Table 108. IVAC Introduction and Business Overview

Table 109. IVAC TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 110. IVAC TB Disease Vaccine Product Offerings

Table 111. IVAC Recent Development

Table 112. Queen Saovabha Mem. Inst Company Information

Table 113. Queen Saovabha Mem. Inst Introduction and Business Overview

Table 114. Queen Saovabha Mem. Inst TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 115. Queen Saovabha Mem. Inst TB Disease Vaccine Product Offerings

Table 116. Queen Saovabha Mem. Inst Recent Development

Table 117. Microgen Company Information

Table 118. Microgen Introduction and Business Overview

Table 119. Microgen TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 120. Microgen TB Disease Vaccine Product Offerings

Table 121. Microgen Recent Development

Table 122. Key Raw Materials Lists

Table 123. Raw Materials Key Suppliers Lists

Table 124. TB Disease Vaccine Downstream Customers

Table 125. TB Disease Vaccine Distributors List

Table 126. Research Programs/Design for This Report

Table 127. Key Data Information from Secondary Sources

Table 128. Key Data Information from Primary Sources

List of Figures

Figure 1. TB Disease Vaccine Product Picture

Figure 2. Global TB Disease Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global TB Disease Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 4. Global TB Disease Vaccine Sales Volume (2019-2030) & (K Units)

Figure 5. Global TB Disease Vaccine Sales Price (2019-2030) & (US$/Unit)

Figure 6. TB Disease Vaccine Report Years Considered

Figure 7. Global TB Disease Vaccine Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global TB Disease Vaccine Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by TB Disease Vaccine Revenue in 2023

Figure 10. TB Disease Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Prevention Vaccines Picture

Figure 12. Post-exposure Vaccines Picture

Figure 13. Others Picture

Figure 14. Global TB Disease Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 15. Global TB Disease Vaccine Sales Value Market Share by Type, 2023 & 2030

Figure 16. Global TB Disease Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 17. Global TB Disease Vaccine Sales Volume Market Share by Type, 2023 & 2030

Figure 18. Global TB Disease Vaccine Price by Type (2019-2030) & (US$/Unit)

Figure 19. Product Picture of Self-Procurement

Figure 20. Product Picture of UNICEF

Figure 21. Product Picture of Others

Figure 22. Global TB Disease Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 23. Global TB Disease Vaccine Sales Value Market Share by Application, 2023 & 2030

Figure 24. Global TB Disease Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 25. Global TB Disease Vaccine Sales Volume Market Share by Application, 2023 & 2030

Figure 26. Global TB Disease Vaccine Price by Application (2019-2030) & (US$/Unit)

Figure 27. North America TB Disease Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 28. North America TB Disease Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 29. Europe TB Disease Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 30. Europe TB Disease Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 31. Asia Pacific TB Disease Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 32. Asia Pacific TB Disease Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 33. South America TB Disease Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 34. South America TB Disease Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 35. Middle East & Africa TB Disease Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 36. Middle East & Africa TB Disease Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 37. Key Countries/Regions TB Disease Vaccine Sales Value (%), (2019-2030)

Figure 38. Key Countries/Regions TB Disease Vaccine Sales Volume (%), (2019-2030)

Figure 39. United States TB Disease Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 40. United States TB Disease Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 41. United States TB Disease Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 42. Europe TB Disease Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 43. Europe TB Disease Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 44. Europe TB Disease Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 45. China TB Disease Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 46. China TB Disease Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 47. China TB Disease Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 48. Japan TB Disease Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 49. Japan TB Disease Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 50. Japan TB Disease Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 51. South Korea TB Disease Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 52. South Korea TB Disease Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 53. South Korea TB Disease Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 54. Southeast Asia TB Disease Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 55. Southeast Asia TB Disease Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 56. Southeast Asia TB Disease Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 57. India TB Disease Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 58. India TB Disease Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 59. India TB Disease Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 60. TB Disease Vaccine Industrial Chain

Figure 61. TB Disease Vaccine Manufacturing Cost Structure

Figure 62. Channels of Distribution (Direct Sales, and Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global TB Disease Vaccine market? zhanKai

The top companies in the global TB Disease Vaccine market are Merck、Japan BCG Lab、Serum Institute of India.

Related Reports

Global TB Disease Vaccine Market Research Report 2025
The global market for TB Disease Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-01
Pages: 91
USD 2900.00
(Single User License)
Global TB Disease Vaccine Market Insights, Forecast to 2030
The vaccine for tuberculosis (TB) is known as BCG (bacille Calmette-Guérin) vaccine. BCG vaccine contains a weakened form of the bacteria (germ) that cause TB. Because it is weakened it doesn't cause TB in healthy people but it helps develop some protection (immunity) against TB.
Published Date: 2024-04-12
Pages: 113
USD 4900.00
(Single User License)
Global TB Disease Vaccine Market Research Report 2024
The vaccine for tuberculosis (TB) is known as BCG (bacille Calmette-Guérin) vaccine. BCG vaccine contains a weakened form of the bacteria (germ) that cause TB. Because it is weakened it doesn't cause TB in healthy people but it helps develop some protection (immunity) against TB.
Published Date: 2024-01-17
Pages: 93
USD 2900.00
(Single User License)

Global TB Disease Vaccine Market Research Report 2025
The global market for TB Disease Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-01
Pages: 91
USD 2900.00 (Single User License)
Global TB Disease Vaccine Market Insights, Forecast to 2030
The vaccine for tuberculosis (TB) is known as BCG (bacille Calmette-Guérin) vaccine. BCG vaccine contains a weakened form of the bacteria (germ) that cause TB. Because it is weakened it doesn't cause TB in healthy people but it helps develop some protection (immunity) against TB.
Published: 2024-04-12
Pages: 113
USD 4900.00 (Single User License)
Global TB Disease Vaccine Market Research Report 2024
The vaccine for tuberculosis (TB) is known as BCG (bacille Calmette-Guérin) vaccine. BCG vaccine contains a weakened form of the bacteria (germ) that cause TB. Because it is weakened it doesn't cause TB in healthy people but it helps develop some protection (immunity) against TB.
Published: 2024-01-17
Pages: 93
USD 2900.00 (Single User License)